These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J. J Bone Miner Res; 1999 Sep 18; 14(9):1583-95. PubMed ID: 10469288 [Abstract] [Full Text] [Related]
7. Relationship between dental panoramic radiographic findings and biochemical markers of bone turnover. Taguchi A, Sanada M, Krall E, Nakamoto T, Ohtsuka M, Suei Y, Tanimoto K, Kodama I, Tsuda M, Ohama K. J Bone Miner Res; 2003 Sep 18; 18(9):1689-94. PubMed ID: 12968679 [Abstract] [Full Text] [Related]
10. Single-center analysis of antiresorptive agent-related osteonecrosis of the jaw in lung cancer patients. Okamura M, Fujita K, Yamamoto Y, Kanai O, Nakatani K, Horimoto K, Hashimoto M, Sawai S, Shimosato M, Yoshida K, Mio T. Asia Pac J Clin Oncol; 2020 Dec 18; 16(6):380-384. PubMed ID: 32893984 [Abstract] [Full Text] [Related]
11. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. Rosen CJ, Chesnut CH, Mallinak NJ. J Clin Endocrinol Metab; 1997 Jun 18; 82(6):1904-10. PubMed ID: 9177404 [Abstract] [Full Text] [Related]
13. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. Guo CY, Thomas WE, al-Dehaimi AW, Assiri AM, Eastell R. J Clin Endocrinol Metab; 1996 Oct 18; 81(10):3487-91. PubMed ID: 8855790 [Abstract] [Full Text] [Related]
14. Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease. Fujieda Y, Doi M, Asaka T, Ota M, Hisada R, Ohnishi N, Kono M, Kameda H, Nakazawa D, Kato M, Amengual O, Takahata M, Yasuda S, Kitagawa Y, Atsumi T. J Bone Miner Metab; 2020 Jul 18; 38(4):581-588. PubMed ID: 32076874 [Abstract] [Full Text] [Related]
17. Predictive factors for refractory stage I and II anti-resorptive agent-related osteonecrosis of the jaw. Shimizu T, Kim M, Dam TT, Kurihara J, Ogawa M, Makiguchi T, Yokoo S. Oral Radiol; 2022 Apr 18; 38(2):240-251. PubMed ID: 34218422 [Abstract] [Full Text] [Related]
18. [Use of a xenogeneic collagen matrix on extraction sockets: a new approach in ARONJ prevention (in german)]. Kuster I, Valdec S, Rücker M, Bichsel D. Swiss Dent J; 2020 Feb 10; 130(2):139-145. PubMed ID: 32031353 [Abstract] [Full Text] [Related]
19. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis. Szentpetery A, McKenna MJ, Murray BF, Ng CT, Brady JJ, Morrin M, Radovits B, Veale DJ, Fitzgerald O. J Rheumatol; 2013 May 10; 40(5):653-62. PubMed ID: 23457381 [Abstract] [Full Text] [Related]
20. Comparison of the acute alterations in serum bone turnover markers and bone mineral density among women with surgical menopause. Bahar S, Abali R, Guzel S, Bozkurt S, Guzel EC, Aral H, Boran AB. Eur J Obstet Gynecol Reprod Biol; 2011 Nov 10; 159(1):194-7. PubMed ID: 21764505 [Abstract] [Full Text] [Related] Page: [Next] [New Search]